Kohnen Thomas, Herzog Michael, Hemkeppler Eva, Schönbrunn Sabrina, De Lorenzo Nina, Petermann Kerstin, Böhm Myriam
Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany.
Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany.
Am J Ophthalmol. 2017 Dec;184:52-62. doi: 10.1016/j.ajo.2017.09.016. Epub 2017 Sep 18.
To evaluate visual performance after implantation of a quadrifocal intraocular lens (IOL).
Setting: Department of Ophthalmology, Goethe University, Frankfurt, Germany.
Twenty-seven patients (54 eyes) received bilateral implantation of the PanOptix IOL (AcrySof IQ PanOptixTM; Alcon Research, Fort Worth, Texas, USA) pre-enrollment. Exclusion criteria were previous ocular surgeries, corneal astigmatism of >1.5 diopter (D), ocular pathologies, or corneal abnormalities. Intervention or Observational Procedure(s): Postoperative examination at 3 months including manifest refraction; uncorrected visual acuity (UCVA) and distance-corrected visual acuity (DCVA) in 4 m, 80 cm, 60 cm, and 40 cm slit-lamp examination; defocus testing; contrast sensitivity (CS) under photopic and mesopic conditions; and a questionnaire on subjective quality of vision, optical phenomena, and spectacle independence was performed.
MAIN OUTCOME MEASURE(S): At 3 months postoperatively, UCVA and DCVA in 4 m, 80 cm, 60 cm, and 40 cm (logMAR), defocus curves, CS, and quality-of-vision questionnaire results.
Mean spherical equivalent was -0.04 ± 0.321 D 3 months postoperatively. Binocular UCVA at distance, intermediate (80 cm, 60 cm), and near was 0.00 ± 0.094 logMAR, 0.09 ± 0.107 logMAR, 0.00 ± 0.111 logMAR, and 0.01 ± 0.087 logMAR, respectively. Binocular defocus curve showed peaks with best visual acuity (VA) at 0.00 D (-0.07 logMAR) and -2.00 D (-0.02 logMAR).
Visual performance of the PanOptix IOL showed good VA at all distances; particularly good intermediate VA (logMAR > 0.1), with best VA at 60 cm; and high patient satisfaction and spectacle independence 3 months postoperatively.
评估四焦点人工晶状体(IOL)植入后的视觉性能。
地点:德国法兰克福歌德大学眼科。
27例患者(54只眼)在入组前接受了双侧PanOptix IOL(AcrySof IQ PanOptixTM;美国德克萨斯州沃思堡的爱尔康研究公司)植入。排除标准为既往眼部手术史、角膜散光>1.5屈光度(D)、眼部病变或角膜异常。干预或观察程序:术后3个月进行检查,包括显然验光;在4米、80厘米、60厘米和40厘米处进行未矫正视力(UCVA)和距离矫正视力(DCVA)的裂隙灯检查;散焦测试;明视和暗视条件下的对比敏感度(CS);以及一份关于主观视觉质量、光学现象和无需眼镜情况的问卷。
术后3个月时,4米、80厘米、60厘米和40厘米处的UCVA和DCVA(对数最小分辨角)、散焦曲线、CS以及视觉质量问卷结果。
术后3个月平均球镜等效度为-0.04±0.321 D。远距离、中间距离(80厘米、60厘米)和近距离的双眼UCVA分别为0.00±0.094对数最小分辨角、0.09±0.107对数最小分辨角、0.00±0.111对数最小分辨角和0.01±0.087对数最小分辨角。双眼散焦曲线显示在0.00 D(-0.07对数最小分辨角)和-2.00 D(-0.02对数最小分辨角)处视力最佳(VA)时出现峰值。
PanOptix IOL的视觉性能在所有距离均显示出良好的视力;特别是中间距离视力良好(对数最小分辨角>0.1),在60厘米处视力最佳;术后3个月患者满意度高且无需佩戴眼镜。